[Ieee_vis] GENCOVERY x Selection process for the last investors

Corinne de GENCOVERY gencovery at postier2.com
Wed Jul 24 13:49:03 CEST 2024


|

Hello,



Following up on the details received regarding GENCOVERY capital increase, we
are finalizing the selection of profiles who will be joining us (the operation
ends shortly).



What 5-minute slot do you have today or within this week, please? And through
which number?



For any needs, here is [my calendar ](https://calendar-
ayomi.com/#/ri/Dreyfus/19056?source=mail&email=\[%email%\])  
As a reminder, here is the link to [the documents  
](https://postier2.com/landing-
ayomi/http://projects.prod/19056/?email=\[%email%\])  
Best regards,

\--

**Corinne  
Head of Investor Relation**

**GENCOVERY**

**+33755546549**



This message and its attachments may contain confidential or privileged
information that may be protected by law; they should not be distributed, used
or copied without authorisation. If you have received this email in error,
please notify the sender and delete this message and its attachments. As
emails may be altered, GENCOVERY is not liable for messages that have been
modified, changed or falsified. Thank you.

|  
---  
|  
---  
  
\---------- Message Replied ---------

>From : Wassim ABOU-JAOUDE

Subject : Join the GENCOVERY venture

To : ieee_vis at listserv.uni-tuebingen.de  
  
|  ![](https://media.ayomi.fr/api/media/public/landing_page/19056/JGGJGJU.JPG)  
---  
  
_[Version Française plus bas]_

###  **ANNOUNCEMENT**

 **It's happening! GENCOVERY is accelerating its commercial expansion!**



The medical sector currently  **lacks effective digital tools to share data**
collected across different entities, leading to **wasted R &D data and delayed
drug development.** Presently, only 1 in 10,000 tested molecules becomes a
drug, and the results of the other tests are not stored anywhere.



This is where **GENCOVERY** and its **Constellab™  **solution come in. Our
project offers a  **revolutionary open-source, multi-cloud digital
infrastructure** that allows sharing all data   **from R &D to production.**
Constellab™ is a SaaS solution based on transparency and flexibility,
providing  **global access to all clinical and real-world data.**



GENCOVERY's growth prospects are very promising. **We will achieve sales of €2
million by 2026.**



 **The market context is therefore promising!**



To finance this acceleration, we offer you the opportunity to become a
shareholder and join the adventure.



In other words, we are giving our network the chance to become shareholders
alongside us.



If you are interested, act quickly: only the first 30 subscriptions will be
accepted!





 _ **Version FR :**_  



###  **ANNONCE**

 **C’est parti ! Notre société GENCOVERY accélère son déploiement commercial
!**



Actuellement, le secteur médical est  **dépourvu d'outils numériques
efficaces** pour partager les données recueillies entre les différentes
structures, entraînant un   **gaspillage des données de R &D **et retardant le
développement de nouveaux médicaments. Actuellement, seulement 1 molécule sur
10 000 testées devient un médicament, et les résultats des autres tests ne
sont stockés nulle part.



C'est ici que  **GENCOVERY** et sa solution   **Constellab™** interviennent.
Notre projet propose une   **infrastructure numérique révolutionnaire** open
source et multi-cloud permettant de partager toutes les données,   **de la R
&D à la production.** Constellab™ est une **solution SaaS** basée sur la
transparence et la flexibilité, offrant un **accès mondial à toutes les
données cliniques et de vie réelle**.



Les perspectives de croissance de GENCOVERY sont très prometteuses.

 **Dans ce contexte et avec notre Business Modèle récurrent, nous réaliserons
un chiffre d'affaires de 2 millions d'ici 2026.**



 **Le contexte du marché est donc prometteur !**

Pour financer cette accélération, nous vous offrons l’opportunité de devenir
actionnaire et de rejoindre l’aventure.

Autrement dit, nous donnons à notre réseau la chance de devenir actionnaire à
nos côtés.

Si vous êtes intéressé, soyez réactif: seules les 30 premières souscriptions
seront acceptées





  
  
---  
  
[ Access documents and learn more  
](https://postier2.com/landing-
ayomi/http://projects.prod/19056/?email=\[%email%\])  
  
---  
  
**Wassim ABOU-JAOUDE  
Associé-Fondateur  
GENCOVERY**  
  
---  
  
This email was sent to ieee_vis at listserv.uni-tuebingen.de because you are part of Wassim ABOU-JAOUDE\'s
network.  

35 Rue de la Bienfaisance,   Paris, Il 75008

http://url7412.postier2.com/asm/unsubscribe/?user_id=6880654&data=otB_CmypDEiEt3mBed149Zbdqlrp55MdKmIDbLFH1xFoMDAwdTAwMLRHpwVq_6BM2Cw9pUlK9STXIO7XvsWhuk2qt85QSHPS3OTDLVxHRE088zD2U3BKRBAdiyp2vcoJa-qc51UVvjx5nVRQ4o85TJcG_uf9JPJLe9N607SyLe5qybp25AtKL1FPZcH7tPVlSlkNlj-DX-wpwPzP5QT8JgKve41nsHQ6i3K5LqAfu8bmat8-4WSwOWRZsRQATuZeZFSLWhiI37yW5yyxUukk0IAqEz3O3XJ09Qy9R66faLF_Wnkglh8Q9KNRMW5Z5TqTOdMYVSIbobW58t8VuKZPUVVpKv9jTyUn5UkVAVzbqMyq1r25ASMBeuNeQ6zSkcW1gdFDDn9gHe-RBpTLfkF-Gn6BFhAOqn66vPr_PpAaNg9mXJop9bvvlrbLuP3FnrXlUJjLZ7T9oQPY1It8QnxD2Ap5Ed7wRIo5S8PAFjKXYGxdkAHP9CAvRgwBxp721AP17prKes7KScaTrG8RirsJuQSs9P0zbONR83L5tYxWUCZrkxZq_vh0Uy-h8cqu7kB8AfElZzoxyNu9kR0_rzkQMgsqafMdZZnkDnUsThuMDuN15mO9N5pTOvhdYqcY1deap7l1bQKg1ukXqC1Dmz28YaZyipF9rdZN_mkmab0-INY8lDxkRITNOA==(http://url7412.postier2.com/asm/unsubscribe/?user_id=6880654&data=otB_CmypDEiEt3mBed149Zbdqlrp55MdKmIDbLFH1xFoMDAwdTAwMLRHpwVq_6BM2Cw9pUlK9STXIO7XvsWhuk2qt85QSHPS3OTDLVxHRE088zD2U3BKRBAdiyp2vcoJa-qc51UVvjx5nVRQ4o85TJcG_uf9JPJLe9N607SyLe5qybp25AtKL1FPZcH7tPVlSlkNlj-DX-wpwPzP5QT8JgKve41nsHQ6i3K5LqAfu8bmat8-4WSwOWRZsRQATuZeZFSLWhiI37yW5yyxUukk0IAqEz3O3XJ09Qy9R66faLF_Wnkglh8Q9KNRMW5Z5TqTOdMYVSIbobW58t8VuKZPUVVpKv9jTyUn5UkVAVzbqMyq1r25ASMBeuNeQ6zSkcW1gdFDDn9gHe-RBpTLfkF-Gn6BFhAOqn66vPr_PpAaNg9mXJop9bvvlrbLuP3FnrXlUJjLZ7T9oQPY1It8QnxD2Ap5Ed7wRIo5S8PAFjKXYGxdkAHP9CAvRgwBxp721AP17prKes7KScaTrG8RirsJuQSs9P0zbONR83L5tYxWUCZrkxZq_vh0Uy-h8cqu7kB8AfElZzoxyNu9kR0_rzkQMgsqafMdZZnkDnUsThuMDuN15mO9N5pTOvhdYqcY1deap7l1bQKg1ukXqC1Dmz28YaZyipF9rdZN_mkmab0-INY8lDxkRITNOA==)

__  
  

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://listserv.uni-tuebingen.de/pipermail/ieee_vis/attachments/20240724/b767b87b/attachment-0001.html>


More information about the ieee_vis mailing list